- Home
- HUBB vs PODD Comparison
HUBB vs PODD Comparison
Compare HUBB & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBB
- PODD
- Stock Information
- Founded
- HUBB 1888
- PODD 2000
- Country
- HUBB United States
- PODD United States
- Employees
- HUBB N/A
- PODD N/A
- Industry
- HUBB Industrial Machinery/Components
- PODD Medical/Dental Instruments
- Sector
- HUBB Technology
- PODD Health Care
- Exchange
- HUBB Nasdaq
- PODD Nasdaq
- Market Cap
- HUBB 19.0B
- PODD 17.2B
- IPO Year
- HUBB N/A
- PODD 2007
- Fundamental
- Price
- HUBB $354.43
- PODD $257.00
- Analyst Decision
- HUBB Hold
- PODD Buy
- Analyst Count
- HUBB 8
- PODD 17
- Target Price
- HUBB $449.38
- PODD $302.56
- AVG Volume (30 Days)
- HUBB 644.2K
- PODD 695.5K
- Earning Date
- HUBB 05-01-2025
- PODD 05-08-2025
- Dividend Yield
- HUBB 1.48%
- PODD N/A
- EPS Growth
- HUBB 10.31
- PODD 96.55
- EPS
- HUBB 14.79
- PODD 5.78
- Revenue
- HUBB $5,594,600,000.00
- PODD $2,071,600,000.00
- Revenue This Year
- HUBB $6.10
- PODD $20.53
- Revenue Next Year
- HUBB $5.39
- PODD $17.42
- P/E Ratio
- HUBB $23.82
- PODD $44.43
- Revenue Growth
- HUBB 1.97
- PODD 22.07
- 52 Week Low
- HUBB $299.43
- PODD $160.19
- 52 Week High
- HUBB $481.35
- PODD $289.46
- Technical
- Relative Strength Index (RSI)
- HUBB 52.92
- PODD 50.41
- Support Level
- HUBB $346.07
- PODD $252.88
- Resistance Level
- HUBB $359.47
- PODD $260.96
- Average True Range (ATR)
- HUBB 10.08
- PODD 7.68
- MACD
- HUBB 0.61
- PODD 1.34
- Stochastic Oscillator
- HUBB 69.42
- PODD 65.40
About HUBB Hubbell Inc
Hubbell is a diversified conglomerate industrial company that mostly competes in the electrical components market. Its products and services serve vital portions of the U.S. electrical supply chain, including transmission and distribution as well as the commercial, industrial, and residential end markets. The company organizes its business into two segments: Utility Solutions Segment and the Electrical Solutions Segment. It derives maximum revenue from Utility Solutions Segment.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.